Welcome to NDF Research
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog
US Life Science Patents to New Zealand assignees, last twelve months
By Stuart Roberts, Senior Analyst, stuart@ndfresearch.com, +61 447 247 909
The US Patent Office issues new patents every Tuesday. New Zealand assignees generally get around healthcare and biotech-related patents a month. Here are the 15 US patents relevant to New Zealand's Life Sciences sector that have issued since 29 December 2015.
US Patent 9,522,159
Title: Treatment and prevention of P. aeruginosa infections using coformycin analogs
Issued: 20 December 2016
Assignee: Viclink (Victoria University of Wellington
Description:  This patent covers inhibitors to the methylthioadenosine deaminase of P. aeruginosa 
US Patent 9,469,675
Title: Anti-inflammatory proteins and methods of preparation and use thereof
Issued: 18 October 2016
Assignee: ManukaMed
PCT application: WO/2012/087160, priority date 22 December 2010
Description:  This patent covers a modified version of the honey glycoprotein apalbumin with greater anti-inflammatory properties than an unmodified apalbumin. The protein comes from Manuka honey, that is, honey from the Manuka tree (Leptospermum scoparium) native to New Zealand. 
US Patent 9,452,155
Title: Injectable antibiotic formulations and their methods of use
Issued: 27 September 2016
Assignee: Bayer New Zealand
PCT application: WO/2014/014364, priority date 17 July 2012
Description:  This patent an improved formulation of the antibiotic penethemate for the treatment of bovine mastitis. 
US Patent 9,415,061
Title: Compositions and methods for treatment of neoplastic disease
Issued: 16 August 2016
Assignee: Innate Immunotherapeutics (ASX: IIL)
Description:  This patent covers the use of Innate's muramyl dipeptide in the treatment of cancer.
US Patent 9,375,413
Title: Methods of reducing milk somatic cell count 
Issued: 28 June 2016
Assignee: AgResearch Ltd
Description:  This patent covers the use of L-arginine supplementation during lactation to reduce milk somatic cell count.
US Patent 9,359,392
Title: Dendrimer scaffolds for pharmaceutical use 
Issued: 28 June 2016
Assignee: Viclink (Victoria University of Wellington)
Description:  This patent covers dendrimers for drug formulation.
US Patent 9,353,349
Title: Synthetic membrane anchors
Issued: 31 May 2016
Assignee: Kode Biotech
Description:  This patent covers water soluble synthetic glycolipids incorporatable into a cell membrane.
US Patent 9,339,479
Title: Dosage forms and related therapies
Issued: 17 May 2016
Assignee: PhilERA (Professor Garth Cooper) 
Description:  This patent covers various dose formulations of copper chelation drugs
US Patent 9,320,781
Title: Dietary supplement for managing gut health
Issued: 26 April 2016
Assignee: Vital Foods
Description:  This patent covers the combination of a kiwifruit extract and an amylase inhibitor.
US Patent 9,315,587
Title: Oligosaccharide compounds
Issued: 19 April 2016
Assignee: Viclink (Victoria University of Wellington) (50%), University of Liverpool (UK, 50%)​
Description:  This patent covers oligosaccharide inhibitors of BACE-1 for the treament of Alzheimer's Disease.
US Patent 9,314,505
Title: Combination treatments and compositions for wound healing comprising viral VEGF
Issued: 19 April 2016
Assignee: Otago Innovation (University of Otago)
Description:  This patent covers combinations of VEGFs and anti-inflammatory cytokines for wound healing.
US Patent 9,314,478
Title: Method of making an anhydrous, fat soluble, chewable drug delivery formulation
Issued: 19 April 2016
Assignee: Argenta
Description:  This patent covers methods of making chewable drug formulations that are palatable and have acceptable shelf life.
US Patent 9,296,789
Title: Vaccines and vaccine components for inhibition of microbial cells
Issued: 29 March 2016
Assignee: Pastoral Greenhouse Gas Research
Description:  This patent covers a vaccine for Methanobrevibacter ruminantium.
US Patent 9,290,501
Title: Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase 
Issued: 22 March 2016
Assignee:  Viclink (Victoria University of Wellington) (50%), Albert Einstein College of Medicine​ (US, 50%)
Description:  This patent covers drugs to treat Pseudomonas aeruginosa infection by attacking that bacterium's quorum sensing pathway.
US Patent 9,255,109
Title: Fungicidal compounds and methods of their use
Issued: 9 March 2016
Assignee:  Auckland UniServices (University of Auckland)
Description:  This patent covers an antifungal compound extracted from Epicoccum nigrum.
US Patent 9,226,968
Title: Carbohydrate-lipid constructs and their use in preventing or treating viral infection
Issued: 6 January 2016
Assignee: Kode Biotech
Description:  This patent covers carbohydrate-lipid constructs that mimic the receptors used by HIV.

Copyright © 2016 NDF Research
Proudly powered by Weebly
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog